OmniAb to Participate in the Jefferies Global Healthcare Conference
![Business Wire](../../../Content/images/providers/BW.png)
OmniAb, Inc. (OABI)
Company Research
Source: Business Wire
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be presenting a corporate overview on Wednesday, June 5th at 8:00 a.m. Eastern time and will be holding one-on-one meetings with investors.A live and archived webcast of the presentation will be available in the Investors section of OmniAb’s website.About OmniAb®OmniAb licenses cutting edge discovery research technology to the pharmaceutical and biotech industry to enable the discovery of next-generation therapeutics. Our technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for our partners’ drug development efforts. At the heart of the OmniAb platform is something we call Biological Intelligence™ (BI), which powers the immune syste
Show less
Read more
Impact Snapshot
Event Time:
OABI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OABI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OABI alerts
High impacting OmniAb, Inc. news events
Weekly update
A roundup of the hottest topics
OABI
News
- OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology [Yahoo! Finance]Yahoo! Finance
- OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyBusiness Wire
- Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 34%? [Yahoo! Finance]Yahoo! Finance
- OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitBusiness Wire
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
OABI
Earnings
- 5/9/24 - Miss
OABI
Sec Filings
- 5/28/24 - Form 4
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- OABI's page on the SEC website